PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29672156 ↗2018Reported benefit

Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.

MouseEndotoxin/LPS

Model: Lipopolysaccharide-induced acute intestinal barrier injury in mice, with a parallel in vitro epithelial wound-healing assay; EGFR-dominant negative Velvet mice used as a genetic control

UDCA stimulated intestinal epithelial cell migration in vitro and in vivo and protected the intestinal barrier from LPS-induced injury, reducing FITC-dextran leakage into serum. Protection was abolished by COX-2 inhibition with rofecoxib and in EGFR-dominant negative Velvet mice, and UDCA increased…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.